BioNexus Gene Lab Corp Common stock (BGLC)

BioNexus Gene Lab Corp Common stock (BGLC) is a Specialty Chemicals company in the Basic Materials sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $3.6M; returns 1 day +0.0%, 1 week -0.9%, 1 year -77.1%.

BioNexus Gene Lab Corp (BGLC) is a Kuala Lumpur, Malaysia-based holding company operating across two primary and one investment segment.

Groups BGLC belongs to

• Southeast Asia
• Healthcare
• Specialty Chemicals
• Biotechnology
• Early Cancer Detection
• Precision Medicine
• Contract Development and Manufacturing Organizations (CDMO)

BGLC financial model: income statement, cash flow and balance sheet